Literature DB >> 15026362

Selective accumulation of mature DC-Lamp+ dendritic cells in tumor sites is associated with efficient T-cell-mediated antitumor response and control of metastatic dissemination in melanoma.

Mojgan Movassagh1, Alain Spatz, Jean Davoust, Serge Lebecque, Pedro Romero, Mikaël Pittet, Donata Rimoldi, Danièle Liénard, Oliver Gugerli, Laurent Ferradini, Caroline Robert, Marie-Françoise Avril, Laurence Zitvogel, Eric Angevin.   

Abstract

The clinical relevance of dendritic cells (DCs) at the tumor site remains a matter of debate concerning their role in the generation of effective antitumor immunity in human cancers. We performed a comprehensive immunohistochemical analysis using a panel of DC-specific antibodies on regressing tumor lesions and sentinel lymph nodes (SLNs) in melanoma patients. Here we show in a case report involving spontaneous regression of metastatic melanoma that the accumulation of DC-Lamp+ DCs, clustered with tumor cells and lymphocytes, is associated with local expansion of antigen-specific memory effector CTLs. These findings were extended in a series of 19 melanoma-positive SLNs and demonstrated a significant correlation between the density of DC-Lamp+ DC infiltrates in SLNs with the absence of metastasis in downstream lymph nodes. This study, albeit performed in a limited series of patients, points to a pivotal role of mature DCs in the local expansion of efficient antitumor T-cell-mediated immune responses at the initial sites of metastasis and may have important implications regarding the prognosis, staging, and immunotherapy of melanoma patients.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15026362     DOI: 10.1158/0008-5472.can-03-2969

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  27 in total

1.  NKp30 isoforms and NKp46 transcripts in metastatic melanoma patients: Unique NKp30 pattern in rare melanoma patients with favorable evolution.

Authors:  Meriem Messaoudene; Giulia Fregni; David Enot; Nicolas Jacquelot; Emmanuelle Neves; Nathalie Germaud; Henri Jean Garchon; Wahid Boukouaci; Ryad Tamouza; Johan Chanal; Marie-Françoise Avril; Antoine Toubert; Laurence Zitvogel; Sylvie Rusakiewicz; Anne Caignard
Journal:  Oncoimmunology       Date:  2016-03-10       Impact factor: 8.110

2.  Morphological observation of tumor infiltrating immunocytes in human rectal cancer.

Authors:  Zun-Jiang Xie; Li-Min Jia; Ye-Chun He; Jiang-Tao Gao
Journal:  World J Gastroenterol       Date:  2006-03-21       Impact factor: 5.742

3.  Chemokine-mediated distribution of dendritic cell subsets in renal cell carcinoma.

Authors:  Peter Middel; Sven Brauneck; Werner Meyer; Heinz-Joachim Radzun
Journal:  BMC Cancer       Date:  2010-10-22       Impact factor: 4.430

4.  Dysfunctional DC subsets in RCC patients: ex vivo correction to yield an effective anti-cancer vaccine.

Authors:  M Gigante; A Blasi; A Loverre; V Mancini; M Battaglia; F P Selvaggi; E Maiorano; A Napoli; G Castellano; W J Storkus; L Gesualdo; E Ranieri
Journal:  Mol Immunol       Date:  2008-11-28       Impact factor: 4.407

Review 5.  The immune contexture and Immunoscore in cancer prognosis and therapeutic efficacy.

Authors:  Daniela Bruni; Helen K Angell; Jérôme Galon
Journal:  Nat Rev Cancer       Date:  2020-08-04       Impact factor: 60.716

Review 6.  The case of oncolytic viruses versus the immune system: waiting on the judgment of Solomon.

Authors:  Robin J Prestwich; Fiona Errington; Rosa M Diaz; Hardev S Pandha; Kevin J Harrington; Alan A Melcher; Richard G Vile
Journal:  Hum Gene Ther       Date:  2009-10       Impact factor: 5.695

7.  CD4+CD25+ Tregs control the TRAIL-dependent cytotoxicity of tumor-infiltrating DCs in rodent models of colon cancer.

Authors:  Stephan Roux; Lionel Apetoh; Fanny Chalmin; Sylvain Ladoire; Grégoire Mignot; Pierre-Emmanuel Puig; Gregoire Lauvau; Laurence Zitvogel; François Martin; Bruno Chauffert; Hideo Yagita; Eric Solary; François Ghiringhelli
Journal:  J Clin Invest       Date:  2008-10-01       Impact factor: 14.808

Review 8.  Inducible Tertiary Lymphoid Structures: Promise and Challenges for Translating a New Class of Immunotherapy.

Authors:  Shota Aoyama; Ryosuke Nakagawa; James J Mulé; Adam W Mailloux
Journal:  Front Immunol       Date:  2021-05-14       Impact factor: 7.561

9.  Dissecting the immune landscape of tumor draining lymph nodes in melanoma with high-plex spatially resolved protein detection.

Authors:  Georgia M Beasley; Aaron D Therien; Eda K Holl; Rami Al-Rohil; Maria Angelica Selim; Nellie E Farrow; Liuliu Pan; Premi Haynes; Yan Liang; Douglas S Tyler; Brent A Hanks; Smita K Nair
Journal:  Cancer Immunol Immunother       Date:  2020-08-19       Impact factor: 6.968

10.  Melanoma-infiltrating dendritic cells: Limitations and opportunities of mouse models.

Authors:  Jared S Klarquist; Edith M Janssen
Journal:  Oncoimmunology       Date:  2012-12-01       Impact factor: 8.110

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.